Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Conscious Dying/Conscious Living: Ketamine-Assisted Psychotherapy (KAP) for Patients at End of Life-A Pilot Study for Palliative and Hospice Care

NCT05214417 is registered in ClinicalTrials.gov with The Ketamine Research Foundation as lead sponsor.

NCT NCT05214417
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05214417 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Conscious Dying/Conscious Living: Ketamine-Assisted Psychotherapy (KAP) for Patients at End of Life-A Pilot Study for Palliative and Hospice Care
Lead sponsor
The Ketamine Research Foundation
Phase
Phase 2
Overall status
Unknown status
Start date
May 1, 2022
Completion date
March 31, 2024
Enrollment
120 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

illness terminal